SCHEMBL5994378

SCHEMBL5994378

Cc1cc(C)c(C(=O)[PH](=O)CCC(=O)c2c(C(F)(F)F)cccc2C(F)(F)F)c(C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
FFAR1 O14842 1/20 0.35
FFAR4 Q5NUL3 1/20 0.35
CYP1A2 P05177 3/20 0.34
CYP3A4 P08684 3/20 0.34
CYP2C19 P33261 3/20 0.34
CYP2D6 P10635 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TSHR P16473 1/20 0.34
HPGD P15428 1/20 0.33
ALDH1A1 P00352 2/20 0.32
ALOX12 P18054 2/20 0.32
TP53 P04637 1/20 0.32
CTNNB1 P35222 2/20 0.32
WNT3A P56704 2/20 0.32
RAPGEF4 Q8WZA2 2/20 0.32
CTSS P25774 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5995908 0.91 ALDH1A1 (0.34) FFAR1FFAR4MEN1KMT2AALDH1A1
SCHEMBL5995234 0.90 ACHE (0.35) FFAR1FFAR4CYP1A2CYP3A4CYP2C19
SCHEMBL5997542 0.84 MAPT (0.36) SMN1; SMN2LMNAFFAR1MEN1KMT2A
SCHEMBL5997924 0.84 MAPT (0.36) SMN1; SMN2LMNAFFAR1MEN1KMT2A
SCHEMBL5996318 0.81 KMT2A (0.43) LMNAMEN1KMT2ATSHRHPGD
SCHEMBL5996163 0.81 KMT2A (0.34) SMN1; SMN2LMNAHTTMEN1KMT2A
SCHEMBL5997688 0.80 ATM (0.40) SMN1; SMN2LMNAHTTMEN1KMT2A
SCHEMBL6448654 0.79 MRGPRX4 (0.40) SMN1; SMN2LMNAHTTCYP3A4CYP2C19
SCHEMBL5996440 0.78 KDM4E (0.35) SMN1; SMN2LMNAMEN1KMT2ATSHR
SCHEMBL5995828 0.78 KDM4E (0.35) SMN1; SMN2LMNAMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7026017-B2 Photoinitiators for acrylic esters; reacting an acyl halide with a metal benzoyl phosphine; cable coatings, screen printing stencils, resist materials, colour filters, electrical encapsulation CIBA SPECIALTY CHEMICALS CORPORATION (US) 2006-04-11 US disclosed
US-6969733-B2 Photoinitiators CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-11-29 US disclosed
US-6737549-B2 PHOTOINITIATORS FOR ACRYLATE COATINGS CIBA SPECIALTY CHEMICALS CORPORATION 2004-05-18 US disclosed
US-20030139485-A1 Photoinitiators WOLF JEAN-PIERRE (CH) 2003-07-24 US disclosed
US-20030130370-A1 Photoinitiators for acrylic esters; reacting an acyl halide with a metal benzoyl phosphine; cable coatings, screen printing stencils, resist materials, colour filters, electrical encapsulation WOLF JEAN-PIERRE (CH) 2003-07-10 US disclosed
US-20020026049-A1 Photoinitiators for acrylate coatings CIBA SPECIALTY CHEMICALS CORP. 2002-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139485-A1 Photoinitiators DHCR24, NR1I3, CBR1 SMN1; SMN2 3940/4885LMNA 763/4885HTT 2638/4885
US-20030130370-A1 Photoinitiators for acrylic esters; reacting an acyl halide with a metal benzoyl phosphine; cable coatings, screen printing stencils, resist materials, colour filters, electrical encapsulation SMARCC1, ARPC5L, DHCR24 SMN1; SMN2 1663/4885LMNA 975/4885HTT 2818/4885
US-20020026049-A1 Photoinitiators for acrylate coatings DHCR24, NR5A1, NR2C2 SMN1; SMN2 4099/4885LMNA 848/4885HTT 2895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.